Medication, Device, Digital Therapeutics Updates*
Flow FL-100 – New Device Approved December 2025
The Flow FL-100, an at-home transcranial direct current stimulation device, was approved as monotherapy or as an adjunctive treatment of moderate to severe major depressive disorder (MDD) in adults.
Caplyta (lumateperone) – New Indication Approved November 2025
Caplyta® (lumateperone), an atypical antipsychotic, was approved as an adjunctive therapy with antidepressants for the treatment of major depressive disorder (MDD) in adults.
Uzedy (risperidone) Extended-Release Injectable Suspension - New Indication Approved October 2025
Uzedy (risperidone), a long-acting injectable atypical antipsychotic, was approved as a monotherapy or adjunctive therapy to lithium or valproate for the maintenance treatment of bipolar I disorder (BD-I) in adults.
Subvenite (lamotrigine) Oral Suspension – New Formulation Approved September 2025
Subvenite (lamotrigine) is an oral suspension formulation of the approved anticonvulsant lamotrigine for use in the treatment of epilepsy and bipolar disorder.
Arynta (lisdexamfetamine dimesylate) Oral Solution – New Formulation Approved June 2025
Arynta is an oral solution formulation of the approved stimulant lisdexamfetamine for use in the treatment of ADHD and binge eating disorder.
Mezofy (aripiprazole) Oral Film – New Formulation Approved April 2025
Mezofy is an oral film formulation of the approved atypical antipsychotic aripiprazole indicated for the treatment of schizophrenia in adult and pediatric patients ages 13 years and older.
Practice Guidelines and Other Products
new! Practice Guideline for the Prevention and Treatment of Delirium, Second Edition
new! Performance in Practice Tool for the Treatment of Patients with Borderline Personality Disorder
The tool allows physicians to earn 20 CME and meets Continuing Certification requirements.
new! Resource Document on Addressing Gambling Disorder in Asian American and Pacific Islander (AAPI) Communities
new! Resource Document on Catatonia
Digital Health
new! Resource Document on College Telehealth Best Practices
Practice Management
new! Resource Document on Preparing in Advance: What Every Psychiatrist and Their Family Should Know About Planning for Unexpected Practice Closures
This guide offers APA members, their families, and colleagues a resource to help navigate the logistical, ethical, and financial complexities of closing a practice on short notice.
new! Resource Document on Prevention of Patient Assaults on Mental Healthcare Employees in Psychiatric Healthcare Settings
This resource document is intended to support psychiatrists, trainees, and other mental healthcare workers and to provide a framework for assessing the adequacy of existing violence prevention policies and a list of resources.
new! Resource Document on Lifestyle Psychiatry
This resource document summarizes the six pillars of lifestyle psychiatry as well as its clinical applications and theories.
Recorded Webinar: 2025 Billing and Documentation Update for Psychiatrists
This webinar highlights the changes to billing and documentation for commonly billed psychiatric services, including telehealth and E&M, that took effect on January 1, 2025.
PowerPoint Slides: 2025 Billing and Documentation Update for Psychiatrists (.pdf)
These slides highlight the changes to billing and documentation for commonly billed psychiatric services, including telehealth and E&M, that took effect on January 1, 2025.
CPT Coding for Telehealth in 2025 (Updated May 7, 2025)
This document reviews the two options available to bill for telehealth that went into effect January 1, 2025, including audio-only care for evaluation and management services
*This webpage provides general educational information only and should not be taken as medical advice or a clinical standard; APA does not endorse or recommend any specific treatments or products and offers this content without warranty. Linked resources reflect the views of their authors and do not necessarily represent the policies or views of the APA.